Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Comparative treatment effectiveness. Effects of program modality and client drug dependence history on drug use reduction.

Hser YI, Anglin MD, Fletcher B.

J Subst Abuse Treat. 1998 Nov-Dec;15(6):513-23.

PMID:
9845865
2.
3.

Does retention matter? Treatment duration and improvement in drug use.

Zhang Z, Friedmann PD, Gerstein DR.

Addiction. 2003 May;98(5):673-84.

PMID:
12751985
4.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
5.
6.

Profiles of clients in government-funded drug user treatment settings.

Hoffman JA, Eckert MA, Koman JJ 3rd, Mayo DW.

Subst Use Misuse. 1996 Mar;31(4):453-77.

PMID:
8851812
7.

Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.

Burdon WM, Dang J, Prendergast ML, Messina NP, Farabee D.

Subst Abuse Treat Prev Policy. 2007 May 15;2:16.

8.

Predicting cocaine use among methadone patients: analysis of findings from a national study.

Dunteman GH, Condelli WS, Fairbank JA.

Hosp Community Psychiatry. 1992 Jun;43(6):608-11.

PMID:
1318260
9.
10.

Remission of psychiatric symptoms among drug misusers after drug dependence treatment.

Gossop M, Marsden J, Stewart D.

J Nerv Ment Dis. 2006 Nov;194(11):826-32.

PMID:
17102706
11.

Effects of readiness for drug abuse treatment on client retention and assessment of process.

Joe GW, Simpson DD, Broome KM.

Addiction. 1998 Aug;93(8):1177-90.

PMID:
9813899
12.

Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993.

Craddock SG, Rounds-Bryant JL, Flynn PM, Hubbard RL.

Am J Drug Alcohol Abuse. 1997 Feb;23(1):43-59.

PMID:
9048146
13.

Interaction of counseling rapport and topics discussed in sessions with methadone treatment clients.

Joe GW, Simpson DD, Rowan-Szal GA.

Subst Use Misuse. 2009;44(1):3-17. doi: 10.1080/10826080802525876.

PMID:
19137479
14.

A randomized controlled trial of interim methadone maintenance.

Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.

Arch Gen Psychiatry. 2006 Jan;63(1):102-9.

PMID:
16389204
15.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. French.

PMID:
19540408
16.

Patterns of current and lifetime substance use in schizophrenia.

Fowler IL, Carr VJ, Carter NT, Lewin TJ.

Schizophr Bull. 1998;24(3):443-55.

PMID:
9718636
17.

Patterns of cocaine use among methadone clients.

Strug DL, Hunt DE, Goldsmith DS, Lipton DS, Spunt B.

Int J Addict. 1985 Aug;20(8):1163-75.

PMID:
4077317
18.

Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).

Hubbard RL, Craddock SG, Anderson J.

J Subst Abuse Treat. 2003 Oct;25(3):125-34.

PMID:
14670518
19.

Costs and effectiveness of substance abuse treatments for homeless persons.

Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K.

J Ment Health Policy Econ. 2002 Mar;5(1):33-42.

PMID:
12529568
20.

HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.

Broome KM, Joe GW, Simpson DD.

AIDS Educ Prev. 1999 Aug;11(4):293-306.

PMID:
10494354
Items per page

Supplemental Content

Support Center